# Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Canonical URL: https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-announces-4-5-million-private-placement-priced-at-the-market-under-nasdaq-rules
Ticker: BJDX
Company: Bluejay Diagnostics
Source: Bluejay Diagnostics
Published: 2025-10-09 19:15 EST
Original Source URL: https://ir.bluejaydx.com
## Summary

ACTON, Mass. , Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an

## Article Body
ACTON, Mass. , Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an
## Recent Company News
- 2026-07-21 10:30 EST — [Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study](https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-announces-successful-completion-of-enrollment-in-the-symon-i-f7cec8c0) — Source: Bluejay Diagnostics
- 2026-06-06 00:13 EST — [Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules](https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-announces-closing-of-up-to-23-7-million-private-placement-pr-08b77eb3) — Source: Bluejay Diagnostics
- 2026-06-02 16:19 EST — [Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules](https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-announces-up-to-23-6-million-private-placement-priced-at-the-market-under-nasdaq-rules) — Source: Bluejay Diagnostics
- 2026-06-02 10:30 EST — [Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership](https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-and-argonaut-manufacturing-services-announce-strategic-partnership) — Source: Bluejay Diagnostics
- 2026-05-07 20:01 EST — [Bluejay Diagnostics Provides First Quarter 2026 Corporate Update](https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-provides-first-quarter-2026-corporate-update) — Source: Bluejay Diagnostics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)